Talk to your healthcare team to see if this therapy could help you manage chronic DPN. The devices are already on the market the recent FDA approval simply allows them to be used for treating pain from DPN as well as certain other neuropathic conditions. When will Intellis and Vanta become available for people with diabetes? In a long-term follow up study, 47% of people treated reported a 50% pain reduction during day and 35% of people treated reported this pain reduction overnight at 24 months. In this study those people treated with spinal cord stimulation had a reduction in their pain, as well as improved health and quality of life after six months when compared to those in the control group not receiving this treatment. Several studies have shown that these types of neurostimulators are effective in treating the pain of DPN. Although this treatment does not address the underlying causes of or cure DPN, this pain reduction can lead to significant improvements in quality of life. These spinal cord stimulators are fully implanted in the body and work by stopping pain signals before they reach the brain – reducing the painful symptoms often associated with DPN. Although these devices were already approved for several chronic pain conditions, the FDA recently indicated that they can be used to treat pain from DPN as well. Intellis is a rechargeable spinal cord stimulator that can give higher doses of electrical stimulation, while Vanta is a recharge-free spinal cord stimulator that can deliver weaker electrical pulses for years without requiring any charging. What are Intellis and Vanta?īoth of these technologies are neurostimulators. To address this gap in available treatment options for painful DPN, Medtronic developed two new technologies named Intellis and Vanta. However, for about 800,000 people with diabetes living in the US with DPN, these options may not be enough – especially given the side effects that come with the currently available drugs for pain. This is especially true for those who have peripheral arterial disease, infections of the legs, trauma which they may not feel, or foot ulcers which may go unnoticed.Ĭurrently, treatments for DPN primarily consist of managing glucose levels and improving Time in Range, as well as certain medications designed to address the painful symptoms of DPN. People with diabetes who have DPN are at greater risk of amputation. This initial sensation may, over time, progress. While the symptoms of DPN vary from person to person, many describe them as numbness, tingling, or burning sensations that start at the toes or fingers and move upward. DPN occurs when high glucose levels damage nerves in the extremities such as the hands, legs, and feet. In January, the FDA approved two of Medtronic’s existing technologies, Intellis and Vanta, for the treatment of pain associated with diabetic peripheral neuropathy (DPN).ĭPN is a complication that affects approximately 30% of people with diabetes. Learn more about these devices and how they address the pain from DPN. The FDA approved Medtronic’s spinal cord stimulators for the treatment of chronic pain from diabetic peripheral neuropathy (DPN).
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |